The ADC 1C1-maleimidocaproyl-MMAF (mcMMAF) triggered apoptosis of EphA2-expressing cells with an IC50 value of 3 ng/mL and suppressed tumour development in vivo. This evidence concerns the gene EPHA2 and neoplasm.